Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.
Strahlenther Onkol. 2022 Oct;198(10):926-933. doi: 10.1007/s00066-022-01996-1. Epub 2022 Aug 17.
For planning CyberKnife stereotactic radiosurgery (CK SRS) of brain metastases (BM), it is essential to precisely determine the exact number and location of BM in MRI. Recent MR studies suggest the superiority of contrast-enhanced 3D fast spin echo SPACE (sampling perfection with application-optimized contrast by using different flip angle evolutions) images over 3D gradient echo (GE) T1-weighted MPRAGE (magnetization-prepared rapid gradient echo) images for detecting small BM. The aim of this study is to test the usability of the SPACE sequence for MRI-based radiation treatment planning and its impact on changing treatment.
For MRI-based radiation treatment planning using 3T MRI in 199 patients with cerebral oligometastases, we compared the detectability of BM in post-gadolinium SPACE images, post-gadolinium MPRAGE images, and post-gadolinium late-phase MPRAGE images.
When SPACE images were used for MRI-based radiation treatment planning, 29.8% and 16.9% more BM, respectively, were detected and included in treatment planning than in the post-gadolinium MPRAGE images and the post-gadolinium late-phase MPRAGE images (post-gadolinium MPRAGE imaging: n = 681, mean ± SD 3.4 ± 4.2; post-gadolinium SPACE imaging: n = 884, mean ± SD 4.4 ± 6.0; post-gadolinium late-phase MPRAGE imaging: n = 796, mean ± SD 4.0 ± 5.3; P < 0.0001, P< 0.0001).
For 3T MRI-based treatment planning of stereotactic radiosurgery of BM, we recommend the use of post-gadolinium SPACE imaging rather than post-gadolinium MPRAGE imaging.
在计划 CyberKnife 立体定向放射外科(CK SRS)治疗脑转移瘤(BM)时,精确确定 MRI 中 BM 的确切数量和位置至关重要。最近的磁共振研究表明,对比增强 3D 快速自旋回波 SPACE(通过使用不同的翻转角演化来实现应用优化对比的采样完美)图像在检测小 BM 方面优于 3D 梯度回波(GE)T1 加权 MPRAGE(磁化准备快速梯度回波)图像。本研究旨在测试 SPACE 序列在基于 MRI 的放射治疗计划中的可用性及其对治疗改变的影响。
在 199 例脑寡转移瘤患者的 3T MRI 基础上进行基于 MRI 的放射治疗计划,我们比较了钆后 SPACE 图像、钆后 MPRAGE 图像和钆后晚期 MPRAGE 图像对 BM 的检测能力。
当使用 SPACE 图像进行基于 MRI 的放射治疗计划时,与钆后 MPRAGE 图像和钆后晚期 MPRAGE 图像相比,分别检测到并纳入治疗计划的 BM 多了 29.8%和 16.9%(钆后 MPRAGE 成像:n=681,平均值±标准差 3.4±4.2;钆后 SPACE 成像:n=884,平均值±标准差 4.4±6.0;钆后晚期 MPRAGE 成像:n=796,平均值±标准差 4.0±5.3;P<0.0001,P<0.0001)。
对于 3T MRI 脑转移瘤立体定向放射外科治疗计划,我们建议使用钆后 SPACE 成像而不是钆后 MPRAGE 成像。